Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Extended Sale! Save on premium data with Claim 60% OFF
Close

ABIOMED Inc (ABMD)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ABIOMED's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
ABIOMED historical data, for real-time data please try another search
381.02 +0.00    +0.00%
21/12 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 380.51 - 381.28
ABIOMED 381.02 +0.00 +0.00%

ABMD Balance Sheet

 
Featured here, the Balance Sheet for ABIOMED Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2022
30/09
 2022
30/06
 2022
31/03
 2021
31/12
Total Current Assets 1062.8 1060.36 976.47 885.01
Cash and Short Term Investments 820.37 844.32 758.61 669.22
Cash - - - -
Cash & Equivalents 182.34 180.49 132.82 144.26
Short Term Investments 638.04 663.83 625.79 524.97
Total Receivables, Net 94.48 91.1 90.61 88.95
Accounts Receivables - Trade, Net 94.48 91.1 90.61 88.95
Total Inventory 102.24 95.37 93.98 90.2
Prepaid Expenses 45.71 29.56 33.28 36.63
Other Current Assets, Total - - - -
Total Assets 1696.54 1703.64 1673.39 1592.88
Property/Plant/Equipment, Total - Net 202.71 206.84 212.01 205.95
Property/Plant/Equipment, Total - Gross 312.13 312.88 314.07 304.88
Accumulated Depreciation, Total -109.42 -106.04 -102.06 -98.93
Goodwill, Net 72.96 74.86 76.79 77.45
Intangibles, Net 36.83 38.17 39.52 40.28
Long Term Investments 297.28 300.75 351.94 374.17
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - - 10.55 3.68
Other Assets, Total 669.77 690.76 645.83 536.23
Total Current Liabilities 134.06 140.76 138.46 126.8
Accounts Payable 35.07 34.8 35.35 32.07
Payable/Accrued - - - -
Accrued Expenses 67.76 77.1 70.69 64.31
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - 2.89 2.59
Other Current liabilities, Total 31.23 28.87 29.53 27.83
Total Liabilities 156.76 167.44 170.07 159.94
Total Long Term Debt - - 0.489 2.13
Long Term Debt - - 0.489 2.13
Capital Lease Obligations - - - -
Deferred Income Tax 0.689 0.735 0.781 0.799
Minority Interest - - - -
Other Liabilities, Total 22.01 25.94 30.34 30.21
Total Equity 1539.79 1536.2 1503.33 1432.94
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.452 0.456 0.455 0.455
Additional Paid-In Capital 904.76 884.96 870.07 853.21
Retained Earnings (Accumulated Deficit) 1125.2 1019.07 964.51 904.19
Treasury Stock - Common -443.97 -330.02 -304.56 -304.42
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -46.64 -38.27 -27.16 -20.49
Total Liabilities & Shareholders' Equity 1696.54 1703.64 1673.39 1592.88
Total Common Shares Outstanding 45.17 45.57 45.55 45.52
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ABMD Comments

Write your thoughts about ABIOMED Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Raul AlKhuwaitem
Raul AlKhuwaitem Aug 10, 2021 12:18PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
TKAT, SOS, ZKIN, FTFT, Crypto companies will get huge gain soon.. Bitcoin start shining again.. Be ready to reach February picks.. Buy and hold forever..
Reply
1 0
Report
TECK CHUAN HO
TECK CHUAN HO May 08, 2020 5:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Under 170.00
Reply
2 4
Report
vaibhav sharma
vaibhav sharma May 08, 2020 5:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
post your reasons.
Reply
0 0
Report
Johnny Fan Hui
Johnny Fan Hui Apr 30, 2020 10:57AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what just happened?! this popped 10% today
Reply
0 0
Report
Le Vent Goldberg
Le Vent Goldberg Feb 13, 2020 10:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Guys what is wrong with this stock?
Reply
1 0
Report
News Feed
News Feed Jan 13, 2020 9:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good time to collect
Reply
1 3
Report
WTI Trader
WTI Trader Jan 13, 2020 9:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
When?
Reply
1 1
Report
kyN Ch
kkyN Jan 13, 2020 9:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ok so whats happening again
Reply
2 1
Report
News Feed
News Feed Jan 13, 2020 9:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good time to collect
Reply
0 1
Report
Ιδομενέας ΒΣ
Ιδομενέας ΒΣ Jan 06, 2020 1:27PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think so ..it's undervalued
Reply
0 0
Report
easy money
easy money Nov 28, 2019 3:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
DO YOU think ti will rise to 250 usd ? soon or very late ?
Reply
1 2
Report
Xpeng Trader
Xpeng Trader Nov 28, 2019 3:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No will drop to $155
Reply
1 3
Report
Rahul Jadhav
Rahul Jadhav Nov 23, 2019 6:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
a report suggested that impella product from abmd is no good.
Reply
1 1
Report
kyN Ch
kkyN Nov 18, 2019 10:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
anyone knows why the drastic drop?
Reply
0 0
Report
Naim Katiman
Naim Katiman Nov 18, 2019 10:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
curious either on why?
Reply
0 0
Report
Rahul Jadhav
Rahul Jadhav Nov 18, 2019 10:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
a report suggested that impella product from abmd is no good.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email